Finance

Lists
Why is 1541 up 2,58%?
Dive Deeper
1541:HKG
ImmuneOnco Biopharmaceuticals(Shngh) Inc
2,98 HKD
+2,58%
(+0,075) 1D
16 ოქტ, 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1541...
Open
2,98 HKD
High
3,07 HKD
Low
2,92 HKD
Mkt. cap
1,28 მლრდ.
Avg. vol.
385,40 ათ.
Volume
273,40 ათ.
52-wk high
11,90 HKD
52-wk low
2,80 HKD
EPS
-0,63 HKD
No. of employees
197
Open
2,98 HKD
High
3,07 HKD
Low
2,92 HKD
Mkt. cap
1,28 მლრდ.
Avg. vol.
385,40 ათ.
Volume
273,40 ათ.
52-wk high
11,90 HKD
52-wk low
2,80 HKD
EPS
-0,63 HKD
No. of employees
197
News stories
From web sources and news partners
About ImmuneOnco Biopharmaceuticals(Shngh) Inc
CEO-
Employees197
Founded2015
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
55,14 მლნ.
55,14 მლნ.
18,62 მლნ.
18,62 მლნ.
Cost of goods sold
555,00 ათ.
555,00 ათ.
-
-
Cost of revenue
555,00 ათ.
555,00 ათ.
-
-
Research and development expenses
77,12 მლნ.
77,12 მლნ.
77,39 მლნ.
77,39 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13,34 მლნ.
13,34 მლნ.
11,60 მლნ.
11,60 მლნ.
Operating expense
90,46 მლნ.
90,46 მლნ.
88,99 მლნ.
88,99 მლნ.
Total operating expenses
91,01 მლნ.
91,01 მლნ.
88,99 მლნ.
88,99 მლნ.
Operating income
-35,87 მლნ.
-35,87 მლნ.
-70,36 მლნ.
-70,36 მლნ.
Other non operating income
4,90 მლნ.
4,90 მლნ.
-6,50 ათ.
-6,50 ათ.
EBT including unusual items
-33,27 მლნ.
-33,27 მლნ.
-82,74 მლნ.
-82,74 მლნ.
EBT excluding unusual items
-33,47 მლნ.
-33,47 მლნ.
-77,67 მლნ.
-77,67 მლნ.
Income tax expense
14,50 ათ.
14,50 ათ.
11,50 ათ.
11,50 ათ.
Effective tax rate
-0,04%
-0,04%
-0,01%
-0,01%
Other operating expenses
-
-
-
-
Net income
-33,00 მლნ.
-33,00 მლნ.
-82,09 მლნ.
-82,09 მლნ.
Net profit margin
-59,84%
-59,84%
-440,81%
-440,81%
Earnings per share
-
-
-
-
Interest and investment income
1,57 მლნ.
1,57 მლნ.
2,28 მლნ.
2,28 მლნ.
Interest expense
-1,43 მლნ.
-1,43 მლნ.
-2,12 მლნ.
-2,12 მლნ.
Net interest expenses
136,00 ათ.
136,00 ათ.
165,50 ათ.
165,50 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-33,84 მლნ.
-33,84 მლნ.
-68,41 მლნ.
-68,41 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები